Siang Chin joins Mammoth Biosciences as its GC

Siang Chin joins Mammoth Biosciences as its GC

Siang Chin has joined the biotech company Mammoth Biosciences as its General Counsel succeeding Gary Loeb, who left his role as Mammoth's GC in September to be General Counsel and Chief Compliance Officer at Intuitive.

Siang Chin joined the company after nearly four years as Intuitive's Vice President and Assistant General Counsel. During the course of her career, Chin has directed legal strategy at life sciences and medtech firms, along with biotech firms, executing transactions and navigating regulatory and intellectual property issues.

She previously served as General Counsel for biotech research firm Affymetrix, where she was a member of the executive team that supervised the company's acquisition by Thermo Fisher Scientific in 2016. She then joined medical equipment manufacturer Varian as Vice President and Assistant General Counsel.

She has also previously worked as an associate at law firms such as Shearman & Sterling and also at Slaughter and May.

Trevor Martin, PhD, Mammoth Biosciences' co-founder and CEO stated, "Siang's broad legal expertise will help us position ourselves for the changing needs of our business and industry."

Mammoth was designated a unicorn late last year after a $150 million Series D. The round was led by Redmile Group, with involvement from investors like Foresite Capital, Senator Investment Group, Sixth Street, Greenspring Associates, Mayfield, and Decheng Capital.

The company creates CRISPR systems, which are powerful tools for editing genomes, allowing researchers to easily alter DNA sequences and modify gene function. Jennifer Doudna, a CRISPR pioneer and Nobel laureate founded the company with Janice Chen, Lucas Harrington, and Martin.